Phenotypic evolution of classic 21-hydroxylase deficiency

William H. Hoffman, Myung Y. Shin, Patricia A. Donohoue, Sandra W Helman, Stephanie L. Brown, George Rosculet, Virendra B. Mahesh

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We describe a female patient who was diagnosed and treated at birth for a classic form of salt-losing congenital adrenal hyperplasia. At 17 years of age, against medical advice, she discontinued both mineralocorticoid and glucocorticoid replacement with no resulting clinical symptoms other than the occurrence of amenorrhoea. Steroid metabolites revealed significant abnormalities of the renin-angiotensin-alosterone axis, as well as of pituitary-adrenal function. Analysis of our patient's DNA showed only one deleterious CYP21 mutation, an intron 2 base pair change activating a cryptic splice site. We speculate that expression of this patient's CYP21 genes may be altered by the effects of ageing or by changes in the steroid milieu.

Original languageEnglish (US)
Pages (from-to)103-109
Number of pages7
JournalClinical Endocrinology
Volume45
Issue number1
DOIs
StatePublished - Aug 10 1996

Fingerprint

Steroids
Congenital Adrenal Hyperplasia
Mineralocorticoids
RNA Splice Sites
Amenorrhea
Angiotensins
Renin
Base Pairing
Introns
Glucocorticoids
Salts
Parturition
Mutation
DNA
Genes
Congenital adrenal hyperplasia due to 21 hydroxylase deficiency

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Hoffman, W. H., Shin, M. Y., Donohoue, P. A., Helman, S. W., Brown, S. L., Rosculet, G., & Mahesh, V. B. (1996). Phenotypic evolution of classic 21-hydroxylase deficiency. Clinical Endocrinology, 45(1), 103-109. https://doi.org/10.1111/j.1365-2265.1996.tb02067.x

Phenotypic evolution of classic 21-hydroxylase deficiency. / Hoffman, William H.; Shin, Myung Y.; Donohoue, Patricia A.; Helman, Sandra W; Brown, Stephanie L.; Rosculet, George; Mahesh, Virendra B.

In: Clinical Endocrinology, Vol. 45, No. 1, 10.08.1996, p. 103-109.

Research output: Contribution to journalArticle

Hoffman, WH, Shin, MY, Donohoue, PA, Helman, SW, Brown, SL, Rosculet, G & Mahesh, VB 1996, 'Phenotypic evolution of classic 21-hydroxylase deficiency', Clinical Endocrinology, vol. 45, no. 1, pp. 103-109. https://doi.org/10.1111/j.1365-2265.1996.tb02067.x
Hoffman WH, Shin MY, Donohoue PA, Helman SW, Brown SL, Rosculet G et al. Phenotypic evolution of classic 21-hydroxylase deficiency. Clinical Endocrinology. 1996 Aug 10;45(1):103-109. https://doi.org/10.1111/j.1365-2265.1996.tb02067.x
Hoffman, William H. ; Shin, Myung Y. ; Donohoue, Patricia A. ; Helman, Sandra W ; Brown, Stephanie L. ; Rosculet, George ; Mahesh, Virendra B. / Phenotypic evolution of classic 21-hydroxylase deficiency. In: Clinical Endocrinology. 1996 ; Vol. 45, No. 1. pp. 103-109.
@article{51e877d28af44681ab2892d6442f3450,
title = "Phenotypic evolution of classic 21-hydroxylase deficiency",
abstract = "We describe a female patient who was diagnosed and treated at birth for a classic form of salt-losing congenital adrenal hyperplasia. At 17 years of age, against medical advice, she discontinued both mineralocorticoid and glucocorticoid replacement with no resulting clinical symptoms other than the occurrence of amenorrhoea. Steroid metabolites revealed significant abnormalities of the renin-angiotensin-alosterone axis, as well as of pituitary-adrenal function. Analysis of our patient's DNA showed only one deleterious CYP21 mutation, an intron 2 base pair change activating a cryptic splice site. We speculate that expression of this patient's CYP21 genes may be altered by the effects of ageing or by changes in the steroid milieu.",
author = "Hoffman, {William H.} and Shin, {Myung Y.} and Donohoue, {Patricia A.} and Helman, {Sandra W} and Brown, {Stephanie L.} and George Rosculet and Mahesh, {Virendra B.}",
year = "1996",
month = "8",
day = "10",
doi = "10.1111/j.1365-2265.1996.tb02067.x",
language = "English (US)",
volume = "45",
pages = "103--109",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Phenotypic evolution of classic 21-hydroxylase deficiency

AU - Hoffman, William H.

AU - Shin, Myung Y.

AU - Donohoue, Patricia A.

AU - Helman, Sandra W

AU - Brown, Stephanie L.

AU - Rosculet, George

AU - Mahesh, Virendra B.

PY - 1996/8/10

Y1 - 1996/8/10

N2 - We describe a female patient who was diagnosed and treated at birth for a classic form of salt-losing congenital adrenal hyperplasia. At 17 years of age, against medical advice, she discontinued both mineralocorticoid and glucocorticoid replacement with no resulting clinical symptoms other than the occurrence of amenorrhoea. Steroid metabolites revealed significant abnormalities of the renin-angiotensin-alosterone axis, as well as of pituitary-adrenal function. Analysis of our patient's DNA showed only one deleterious CYP21 mutation, an intron 2 base pair change activating a cryptic splice site. We speculate that expression of this patient's CYP21 genes may be altered by the effects of ageing or by changes in the steroid milieu.

AB - We describe a female patient who was diagnosed and treated at birth for a classic form of salt-losing congenital adrenal hyperplasia. At 17 years of age, against medical advice, she discontinued both mineralocorticoid and glucocorticoid replacement with no resulting clinical symptoms other than the occurrence of amenorrhoea. Steroid metabolites revealed significant abnormalities of the renin-angiotensin-alosterone axis, as well as of pituitary-adrenal function. Analysis of our patient's DNA showed only one deleterious CYP21 mutation, an intron 2 base pair change activating a cryptic splice site. We speculate that expression of this patient's CYP21 genes may be altered by the effects of ageing or by changes in the steroid milieu.

UR - http://www.scopus.com/inward/record.url?scp=0030011162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030011162&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2265.1996.tb02067.x

DO - 10.1111/j.1365-2265.1996.tb02067.x

M3 - Article

VL - 45

SP - 103

EP - 109

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 1

ER -